Back
Biogen Stock Predictions
Sponsored
BIIB
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
38
BIIB
Biogen
Last Price:
176.91
Seasonality Move:
5.71%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeBiogen Stock Forecast
- Over the next 52 weeks, Biogen has on average historically risen by 36.4% based on the past 33 years of stock performance.
- Biogen has risen higher in 18 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Biogen Stock Undervalued?
The current Biogen [BIIB] share price is $176.93. The Score for BIIB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal. - BIIB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Biogen Stock Go Up Next Year?
- Over the next 52 weeks, Biogen has on average historically risen by 36.4% based on the past 33 years of stock performance.
Biogen Stock Rating
Sell
38
Biogen (BIIB)
is a Sell
Is Biogen overpriced?
- Biogen has risen higher in 18 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Biogen Stock Price History
Stock Information
Stock Info
Exchange:
S&P500
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biogen.com
52-Week Data
52-Week High:
268.30
52-Week Low:
170.71
Prediction Charts
Market Cap:
25.78B
Price in USD:
176.93
Volume:
2.46M
Beta:
0.93
Technical Analysis
SMA50:
191.83
SMA100:
204.96
SMA200:
213.36
52-Wk Change:
-29.09%
Stock Predictions
-
Is Biogen stock public?
Yes, Biogen is a publicly traded company. -
What is the Biogen stock quote today?
The Biogen stock price is 176.93 USD today. -
How to buy Biogen stock online?
You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 191.68 | 189.00 | 192.16 | 188.90 |
Oct-18 | 188.22 | 190.16 | 191.19 | 187.94 |
Oct-21 | 190.16 | 184.65 | 190.40 | 184.02 |
Oct-22 | 183.81 | 185.90 | 186.54 | 182.80 |
Oct-23 | 184.88 | 182.98 | 185.82 | 182.11 |
Oct-24 | 184.79 | 183.86 | 185.72 | 183.28 |
Oct-25 | 185.70 | 181.69 | 187.58 | 181.25 |
Oct-28 | 182.48 | 185.01 | 185.60 | 181.73 |
Oct-29 | 184.82 | 183.47 | 187.28 | 183.19 |
Oct-30 | 184.63 | 181.18 | 185.00 | 177.93 |
Oct-31 | 178.11 | 174.00 | 179.48 | 173.88 |
Nov-1 | 173.65 | 173.79 | 175.99 | 173.14 |
Nov-4 | 173.22 | 173.52 | 174.85 | 170.71 |
Nov-5 | 172.71 | 176.93 | 177.25 | 170.72 |
Biogen Earnings
Biogen Earnings Report: Per Share Biogen Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biogen Forecast Revenue Growth
Biogen Stock Analysis: Historical quarterly revenues per share for Biogen and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.43 per share.
* Biogen stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.